M&A Deal Summary |
|
|---|---|
| Date | 2020-05-13 |
| Target | Virbac SA - SENTINEL U.S. Rights |
| Sector | Life Science |
| Buyer(s) | Merck |
| Sellers(s) | Virbac |
| Deal Type | Divestiture |
| Deal Value | 400M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1891 |
| Sector | Life Science |
| Employees | 70,000 |
| Revenue | 60.1B USD (2023) |
Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 23 of 35 |
| Sector (Life Science) | 20 of 32 |
| Type (Divestiture) | 1 of 2 |
| State (New Jersey) | 3 of 3 |
| Country (United States) | 18 of 27 |
| Year (2020) | 1 of 4 |
| Size (of disclosed) | 22 of 27 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-03-12 |
StayWell
Yardley, Pennsylvania, United States Staywell is a health empowerment company that enables populations to improve health outcomes through the science of behavior change. Staywell was founded in 1978 and is headquartered in St. Paul, Minnesota. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-05-26 |
Themis Bioscience
Vienna, Austria Themis Bioscience GmbH is a developer of immunomodulation therapies for infectious diseases and cancer. Through advanced understanding of immune system mechanisms, the company has built a sophisticated and versatile technology platform for the discovery, development and production of vaccines as well as other immune system activation approaches. Themis Bioscience is based in Vienna, Austria. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1968 |
| Sector | Healthcare Services |
| Employees | 5,459 |
| Revenue | 1.2B EUR (2023) |
Virbac is an veterinarian independent pharmaceutical company. Virbac was founded in 1968 and is based in Carros, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Divestiture) | 1 of 1 |
| State (New Jersey) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2020) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-27 |
Eli Lilly - Sentinel and Spectrum Brands
Indianapolis, Indiana, United States Virbac would acquire a combination of titles and rights for the United States on trademarks, marketing authorizations, patents, know-how, customer lists and other assets, related to two major parasiticides for dogs: Sentinel® Flavor Tabs and Sentinel® Spectrum, currently marketed in the United States by Novartis Animal Health. |
Buy | $410M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-02 |
Globion
Hyderabad, India Globion is a poultry vaccine specialist who has developed robust know-how and expertise in the development, manufacturing, and commercialization of live and inactivated vaccines targeting a large array of avian pathogens. Globion is based in Hyderabad, India. |
Buy | - |
